Literature DB >> 12574249

Diagnosing herpesvirus infections by real-time amplification and rapid culture.

G J J van Doornum1, J Guldemeester, A D M E Osterhaus, H G M Niesters.   

Abstract

Procedures using real-time technique were developed to demonstrate the presence of herpes simplex virus type 1 (HSV-1) and HSV-2, varicella zoster virus (VZV), and cytomegalovirus (CMV) in miscellaneous clinical specimens. The assays were compared to rapid culture using centrifugation followed by detection with monoclonal antibodies. A total of 711 consecutive samples were collected from different patient groups. Throat swabs were obtained from transplant patients; dermal or oral specimens were collected from patients suspected for VZV or HSV infection. Genital specimens were taken from patients who attended the Clinic for Sexually Transmitted Diseases at the Dijkzigt Hospital Rotterdam presenting with symptoms of a primary genital ulcer. Nucleic acid extraction was carried out using a MagnaPure LC instrument. The amplification steps were performed on the ABI Prism 7700 sequence detection system. To monitor the process of extraction and amplification, a universal control consisting of seal herpesvirus type 1 (PhHV-1) was added to the clinical specimens. By culture 127 of 668 (19%) samples were positive for HSV-1, 72 of 668 (10.8%) specimens were positive for HSV-2, and 17 of 366 (4.6%) were positive for VZV. Using real-time amplification the numbers of positive specimens were 143 of 668 (21.4%), 97 of 668 (14.5%), and 27 of 366 (7.4%), respectively. Eighty-six specimens were tested for CMV, 12 (14.0%) were positive by culture, and 17 (19.8%) were positive by real-time PCR. The clinical data of the patients with discrepant results were reviewed thoroughly. In all cases the patients with only real-time PCR-positive results could be considered as truly infected. We concluded that the real-time amplification technique is suitable for the detection of human herpesvirus infection. It offers a semiquantitative and reliable assay with a quick result that is more sensitive than rapid culture, especially for the diagnosis of HSV-2 and VZV infections.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12574249      PMCID: PMC149665          DOI: 10.1128/JCM.41.2.576-580.2003

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  10 in total

Review 1.  Quantitative molecular analysis of virus expression and replication.

Authors:  M Clementi
Journal:  J Clin Microbiol       Date:  2000-06       Impact factor: 5.948

2.  Evaluation of LightCycler PCR for implementation of laboratory diagnosis of herpes simplex virus infections.

Authors:  M J Espy; T K Ross; R Teo; K A Svien; A D Wold; J R Uhl; T F Smith
Journal:  J Clin Microbiol       Date:  2000-08       Impact factor: 5.948

3.  Rapid detection of herpes simplex virus DNA in genital ulcers by real-time PCR using SYBR green I dye as the detection signal.

Authors:  Carmen Aldea; Carmen P Alvarez; Lola Folgueira; Rafael Delgado; Joaquín R Otero
Journal:  J Clin Microbiol       Date:  2002-03       Impact factor: 5.948

4.  Detection of herpes simplex virus DNA in genital and dermal specimens by LightCycler PCR after extraction using the IsoQuick, MagNA Pure, and BioRobot 9604 methods.

Authors:  M J Espy; P N Rys; A D Wold; J R Uhl; L M Sloan; G D Jenkins; D M Ilstrup; F R Cockerill; R Patel; J E Rosenblatt; T F Smith
Journal:  J Clin Microbiol       Date:  2001-06       Impact factor: 5.948

5.  Diagnosing genital ulcer disease in a clinic for sexually transmitted diseases in Amsterdam, The Netherlands.

Authors:  S M Bruisten; I Cairo; H Fennema; A Pijl; M Buimer; P G Peerbooms; E Van Dyck ; A Meijer; J M Ossewaarde; G J van Doornum
Journal:  J Clin Microbiol       Date:  2001-02       Impact factor: 5.948

6.  Quantification of human cytomegalovirus DNA in bone marrow transplant recipients by real-time PCR.

Authors:  F Griscelli; M Barrois; S Chauvin; S Lastere; D Bellet; J H Bourhis
Journal:  J Clin Microbiol       Date:  2001-12       Impact factor: 5.948

7.  Diagnosis of varicella-zoster virus infections in the clinical laboratory by LightCycler PCR.

Authors:  M J Espy; R Teo; T K Ross; K A Svien; A D Wold; J R Uhl; T F Smith
Journal:  J Clin Microbiol       Date:  2000-09       Impact factor: 5.948

8.  Development of a fluorogenic polymerase chain reaction assay (TaqMan) for the detection and quantitation of varicella zoster virus.

Authors:  K Hawrami; J Breuer
Journal:  J Virol Methods       Date:  1999-04       Impact factor: 2.014

9.  Characterization of phocid herpesvirus-1 and -2 as putative alpha- and gammaherpesviruses of North American and European pinnipeds.

Authors:  T C Harder; M Harder; H Vos; K Kulonen; S Kennedy-Stoskopf; B Liess; M J Appel; A D Osterhaus
Journal:  J Gen Virol       Date:  1996-01       Impact factor: 3.891

10.  Development of a high-throughput quantitative assay for detecting herpes simplex virus DNA in clinical samples.

Authors:  A J Ryncarz; J Goddard; A Wald; M L Huang; B Roizman; L Corey
Journal:  J Clin Microbiol       Date:  1999-06       Impact factor: 5.948

  10 in total
  79 in total

1.  Human herpesvirus 8 load in matched serum and plasma samples of patients with AIDS-associated Kaposi's sarcoma.

Authors:  Abeltje M Polstra; Remco Van Den Burg; Jaap Goudsmit; Marion Cornelissen
Journal:  J Clin Microbiol       Date:  2003-12       Impact factor: 5.948

2.  Stable and noncompetitive RNA internal control for routine clinical diagnostic reverse transcription-PCR.

Authors:  Kate E Dingle; Derrick Crook; Katie Jeffery
Journal:  J Clin Microbiol       Date:  2004-03       Impact factor: 5.948

3.  Diagnosis of genital herpes by real time PCR in routine clinical practice.

Authors:  M Ramaswamy; C McDonald; M Smith; D Thomas; S Maxwell; M Tenant-Flowers; A M Geretti
Journal:  Sex Transm Infect       Date:  2004-10       Impact factor: 3.519

4.  Sequencing and resolution of amplified herpes simplex virus DNA with intermediate melting curves as genotype 1 or 2 by LightCycler PCR assay.

Authors:  Nicolas C Issa; Mark J Espy; James R Uhl; Thomas F Smith
Journal:  J Clin Microbiol       Date:  2005-04       Impact factor: 5.948

5.  Genital herpes.

Authors:  A M Geretti
Journal:  Sex Transm Infect       Date:  2006-12       Impact factor: 3.519

6.  Clinical value of Treponema pallidum real-time PCR for diagnosis of syphilis.

Authors:  R Heymans; J J van der Helm; H J C de Vries; H S A Fennema; R A Coutinho; S M Bruisten
Journal:  J Clin Microbiol       Date:  2009-12-09       Impact factor: 5.948

7.  Comparison of specimen processing and nucleic acid extraction by the swab extraction tube system versus the MagNA Pure LC system for laboratory diagnosis of herpes simplex virus infections by LightCycler PCR.

Authors:  N C Issa; M J Espy; J R Uhl; W S Harmsen; J N Mandrekar; R E Gullerud; M D Davis; T F Smith
Journal:  J Clin Microbiol       Date:  2005-03       Impact factor: 5.948

8.  Treatment-dependent loss of polyfunctional CD8+ T-cell responses in HIV-infected kidney transplant recipients is associated with herpesvirus reactivation.

Authors:  O Gasser; F Bihl; S Sanghavi; C Rinaldo; D Rowe; C Hess; D Stablein; M Roland; P Stock; C Brander
Journal:  Am J Transplant       Date:  2009-04       Impact factor: 8.086

9.  A systemic neutrophil response precedes robust CD8(+) T-cell activation during natural respiratory syncytial virus infection in infants.

Authors:  Michaël V Lukens; Alma C van de Pol; Frank E J Coenjaerts; Nicolaas J G Jansen; Vera M Kamp; Jan L L Kimpen; John W A Rossen; Laurien H Ulfman; Carline E A Tacke; Marco C Viveen; Leo Koenderman; Tom F W Wolfs; Grada M van Bleek
Journal:  J Virol       Date:  2009-12-16       Impact factor: 5.103

10.  Legionella pneumophila DNA in serum samples during Legionnaires' disease in relation to C-reactive protein levels.

Authors:  F L van de Veerdonk; C P C de Jager; J J A Schellekens; C J J Huijsmans; F Beaumont; M H A Hermans; P C Wever
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2008-10-15       Impact factor: 3.267

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.